A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient.

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

A new treatment for an aggressive blood cancer developed in Australia is proving a lifesaver for patients who had run out of ...

We recently compiled a list of the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2024. In this article, we are going to ...

Cardiovascular disease, manifesting principally as heart attacks and brain strokes, is the leading cause of death globally.

Discover a study that aims to customise CIC profiles for patients, providing insights into which stages of the cycle are most ...

ARK Investment Management LLC, more commonly known as ARK Invest, is an American investment management firm headquartered in ...

Paris: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) ...

A 16-year-old boy has had almost half his tongue removed after a sinister ulcer turned into a Grade 4 cancer with experts ...

From an evolutionary standpoint, dopamine rewards you when you’re doing things necessary for survival, such as eating and ...

Barcelona goalkeeper Marc-Andre ter Stegen is on the path to recovery after suffering a serious ACL injury during the match ...